Our results suggest that HBV-induced upregulation of PSMB5, which persists during HCC development, may alter proteostasis and MHC I presentation, thereby shaping immune recognition in hepatocytes and potentially influencing disease progression. The gene discussed is PSMB5; the disease is hepatocellular carcinoma.